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Abstract
OBJECTIVE: To investigate effects of Xinfeng cap-
sule (XFC) on cardiac function in rats with adjuvant
arthritis (AA) and explore the mechanism of these
effects.
METHODS: Forty-eight rats were randomly divided
into normal control (NC), model control (MC), meth-
otrexate (MTX) and XFC groups of equal size. In all
groups except for the NC group, 0.1 mL Freund's
complete adjuvant (FCA) was intracutaneously in-
jected in the right rear vola pedis to induce inflam-
mation. Drugs were applied beginning 19 days af-
ter induction of inflammation. Normal saline was
administered to the NC and MC groups and 1 mg/
100 g MTX (weekly) and 0.12 g/100 g XFC (daily) to
the MTX and XFC groups, respectively. Rats were
sacrificed after 30 day of treatment. Toe swelling de-
gree (TSD), arthritis index (AI), cardiac function and
expression of nuclear factor kappa B (NF-κB) / tu-
mor necrosis factor alpha (TNF-α) and transforming
growth factor beta 1 (TGF-β1)/Smads pathway pro-
teins were measured.
RESULTS: In the MC group, TSD and AI were
greatly increased, while parameters of cardiac
function were decreased and morphological
analysis showed myocardial cell damage. Expres-
sion of TNF-α, NF-κB, Smad2, P-Smad2, Smad4
and TGF-β1 proteins were elevated in cardiac tis-
sue, while Smad7 expression was decreased.
TSD and AI values closely correlated to parame-
ters of cardiac function and to levels of proteins
in the NF-κB/TNF-α and TGF-β1/Smads path-
ways. Certain correlations were identified among
TGF-β1 and NF-κB, Smad2, P-Smad2 and Smad4.
With XFC intervention, both TSD and AI were
decreased and parameters of cardiac function
and ultrastructure of myocardial cells improved.
Expressions of NF-κB, Smad2, and Smad4 pro-
teins were greatly decreased and Smad7 expres-
sion was elevated, as compared with levels in
the MC and MTX groups.
CONCLUSION: XFC regulates expression of pro-
teins in the NF-κB/TNF-α and TGF-β1/Smads path-
ways, decreases immune complex deposition in car-
diac tissue and improves cardiac function in AA rats
via upregulation of Smad7.
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INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune
disease characterized by chronic erosive joint inflamma-
tion. Synovitis and vasculitis are pathological features
of RA that can lead to cardiac injury in addition to
joint deformity.1 Research indicates that the incidence
of cardiac injury caused by RA is 28%-35%.2 Cardiac
injury by RA is manifested as impairment of cardiac
function. Joint and extra-articular changes in RA are re-
capitulated in adjuvant-induced arthritis (AA) models,
including those induced by Freund's adjuvant (FCA)
that are typically used to study RA. Pathological and
clinical changes that follow FCA-induced inflamma-
tion in AA models are very similar to those observed in
human RA.3 The joints and synovia in AA rats exhibit-
ed massive inflammatory cell infiltration, swelling or
adhesion of articular capsule and pathological changes
characterized by synovitis and vasculitis.4 RA vasculitis
may further lead to injuries of other visceral organs.
The heart is rich in blood vessels and fibrous tissue,
and is one of the organs most affected by extra-articu-
lar changes occurring in RA. Mechanisms of cardiac in-
jury in RA have been mostly attributed to excessive ac-
tivation of nuclear factor kappa B (NF-κB)/ tumor ne-
crosis factor alpha (TNF-α) and transforming growth
factor beta 1 (TGF-β1) / Smads pathways.5 Immuno-
suppressive and anti-inflammatory approaches primari-
ly used for treating RA are poorly tolerated by patients
because of adverse effects on the gastrointestinal and
blood systems. Traditional Chinese medicine (TCM)
has played a prominent role in treating RA and its ex-
tra-articular changes. It has been reported that Xinfeng
capsule (XFC), a TCM believed to fortify the spleen,
resolve dampness, and unblock collateral blood vessels,
greatly improves articular symptoms in RA.6 According
to clinical observations in RA patients XFC improved
morning stiffness, joint swelling, joint tenderness as
well as chest depression, heart palpitations and flush-
ing. In AA rats, XFC was reported to reduce synovial
inflammation, improve indexes of cardiac function,
and reduce cardiac injury.4 In this study, we further ex-
plore the mechanism of XFC in reducing cardiac inju-
ry in AA rats by measuring cardiac levels of NF-κB/
TNF-α and TGF-β1 / Smads proteins.
MATERIALS ANDMETHODS
Drugs and reagents
XFC, supplied by the preparation center at the First Af-
filiated Hospital of Anhui University of Chinese Medi-
cine (Hefei, China, batch No. 20100314), was com-
posed of Yiyiren (Semen Coicis), Huangqi (Radix Astrag-
ali Mongolici), Wugong (Scolopendra) and Leigongteng
(Radix et Rhizoma Tripterygii). Each 0.5 g capsule was
approved by the authorities in Anhui province, China
(Z20050062). Methotrexate (MTX), 2.5 mg per tab-
let, was produced by SINE, Shanghai Pharma (Shang-
hai, China) and approved by state authorities
(H31020644; batch No. 20110108). FCA (batch No.
JP020031P) was from Sigma Aldrich (St. Louis, MO,
USA). Anti-TNF-α, -NF-κB, and -β-actin antibodies
in rats were from Santa Cruz Biotechnology (Santa
Cruz, CA., USA). Anti- Smad2, - Smad4, - Smad7,
and -TGF-β1antibodies in rats were also from Santa
Cruz Biotechnology.
Instruments
The rat foot volume measuring instrument (KH-
YLS-7C) was purchased from Beijing KanghuiSD Tech-
nology Co., Ltd (Beijing, China). Color Doppler ultra-
sound (GEL-400) was from General Electric (Fairfield,
CT, USA). Multipurpose polygraph (MP-150) and im-
age analysis system (Penguin-600 CL-OYLMPUS
BX51) were from BIOPAC Systems, Inc. (New York,
NY, USA). The electrophoresis apparatus (EPS-301)
was from Amersham (Piscataway, NJ, USA). The
Gel-pro analyzer (Gel Doc XR) was from Bio-Rad
(Hercules, CA, USA). The transmission electron micro-
scope (DXT-75) was developed by Shanghai Institute
of Optics and Electronics (Shanghai, China).
AA model and drug administration
Forty-eight male Wistar rats, specific pathogen-free
grade, were supplied by Anhui Provincial Experimental
Center (License No. 2010-0004). The body weights
ranged from 180-220 g. After a 1-week adaptation peri-
od, rats were divided into normal control (NC) (n =
12) and AA (n = 36) groups using a random number
table. Rats in the AA group each received an intracuta-
neous injection of 0.1 mL FCA to the right vola pedis
to induce inflammation. At d 12 after FCA-induced in-
flammation, 0.05 mL FCA was injected at the base of
the tail of AA rats to intensify immunization.6 On day
19 after FCA-induced inflammation, the rats in the
AA model group were randomly divided into XFC,
MTX and model control (MC) groups, each with 12
rats. Drug administration began on the same day, at
drug doses approximately 10 times those clinically
used in adults. Specifically, XFC (0.12 g/100 g) was ad-
ministered intragastrically once per day to the XFC
group. In the MTX group, MTX (1 mg/100 g) was ad-
ministered intragastrically once per week. The NC and
MC groups received intragastric administration of nor-
mal saline (1 mL/100 g) once per day. In the MTX
group, on days when drug was not administered, rats
received intragastric administration of normal saline
(1 mL/100 g). These treatments continued for a total
of 30 day.
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Calculation of toe swelling degree and arthritis index
Toe swelling degree (TSD) was measured with a rat
foot volume instrument and arthritis index (AI) was
calculated by the scoring system described below, as
compared with joints without pathological changes.
TSD was obtained by measuring the volume of each
rat's rear toe every 3 d from the first day before induc-
ing inflammation until the 30th day after drug admin-
istration. TSD was calculated according to the formu-
la: (Vt-Vn)/Vn × 100% , with Vn and Vt indicating
the volume of toes before and after AA induction, re-
spectively. Calculation of AI resulted from observing
and recording degrees of pathological changes in the
joints of the whole body once every 3 day. The AI was
classified using a five-scale method: 0, no swelling; 1
point, swelling on the joint of the little toe; 2 points,
swelling on the metatarsal phalange joint and foot; 3
points, swelling on the hindpaw below ankle swelling;
4 points, swelling on the hindpaw and including ankle
swelling. The sum of points for each rat was calculated,
and the highest possible score was 12 points.7
Cardiac function examined by hemodynamics
Twenty-four hours after the last drug administration,
hemodynamics was measured in each group of rats. Af-
ter the rats were anesthetized intraperitoneally, the skin
was cut along the middle of the neck, the right com-
mon carotid artery exposed and the puncture needle of
the vagina vasorum was imbedded. The end of vaso-
rum was connected to a pressure converter and multi-
purpose polygraph by a heparinized plastic tube and
then vagina vasorum retrograded and entered left ven-
tricle via aortic valve. Left ventricular systolic pressure
(LVSP), left ventricular end-diastolic pressure
(LVEDP) and maximum rate of left ventricular pres-
sure (± dp/dtmax) were recorded along with synchro-
nous recording of the heart rate (HR). In the process
of placing the cannula, the end of the vasorum was
connected to a converter and multipurpose polygraph
to determine cannula location. The distinctive pressure
waveform of the left ventricle indicated that the cannu-
la had entered the left ventricle. The ± dp/dtmax was
considered a reliable index of myocardial contractility.
The mean values of HR, LVEDP, and ± dp/dtmax were
recorded over 2 min.
Cardiac tissue morphology
For morphological observation of the myocardium, 24
h after the last drug treatment, myocardial tissue of rats
was immersed for 8 h in 4% paraformaldehyde (Guo-
chen Chemicals Co., Ltd., Nanjing, China) for fixa-
tion and then dehydrated, permeabilized, immersed in
paraffin, embedded and cut into 6-μm sections for he-
matoxylin-eosin (HE) staining. HE stained sections
were observed under an Olympus microscope (CX31-
32C02, Tokyo, Japan) and photographed. For myocar-
dial cell ultrastructure observations, cardiac tissue was
cut into 1-mm3 pieces after rinsing with phosphate buf-
fer. Tissue samples were immersed in 10% glutaralde-
hyde (Xinjing Chemical Co., Ltd., Jingzhou, China)
for fixation, 4% glutaraldehyde (Xinjing Chemical
Co., Ltd., Jingzhou, China) for pre-fixation, 1% osmic
acid (Xinjing Chemical Co., Ltd., Jingzhou, China) for
fixation with stationary liquid and then dehydrated in
graded acetone solutions, embedded in Epon812 (Xin-
jing Chemical Co., Ltd., Jingzhou, China), cut into
sections, stained with uranyl acetate (Xinjing Chemical
Co., Ltd., Jingzhou, China), fully rinsed with double
distilled water, stained again with lead citrate (Xinjing
Chemical Co., Ltd., Jingzhou, China), dried at room
temperature and observed under a transmission elec-
tron microscope (TEM).
Expression of pathway-related proteins
Total protein from cardiac and pulmonary tissue was
extracted by a protein extraction solution, electropho-
resed on SDS polyacrylamide gels then transferred to
nitrocellulose membranes and membranes were
blocked in 0.5% bovine serum for 1 h. Mouse anti-hu-
man TNF-α, NF-κB, TGF-β1, Smad2, Smad4, and
Smad7 antibodies, each diluted at 1∶1000, were added
and membranes were incubated at 4 ℃ overnight, and
then washed three times with washing buffer. After
that, membranes were incubated with goat anti-mouse
IgG-HRP (Santa Cruz, CA., USA) diluted at 1∶2000
for 1 h, then washed three times. Bands were detected
using a luminescence based Gel image analyzer (Gel
Doc XR, Hercules, CA, USA). The optical densities of
bands corresponding to TNF-α, NF-κB, TGF-β1,
Smad2, Smad4, and Smad7 / β-actin were normalized
to those of corresponding bands from normal cardio-
pulmonary tissue.
Statistical analysis
SPSS17.0 statistical software (SPSS Inc., Chicago, IL,
USA) was used. Values were expressed as mean ± stan-
dard deviation ( xˉ ± s) and the ANOVA test was used
for comparison of means among the groups. The Inde-
pendent t test was applied for comparison between
groups, and hierarchical clustering analysis was used
for relationships among each index. P < 0.05 was re-
garded as statistically significant.
RESULTS
Influences of XFC on inflammatory response of rat's
joint
Before FCA-induced inflammation, there were no sig-
nificant differences in TSD or AI among the groups
(P > 0.05). On the first day before drug administration
(the 19th day of FCA-induced inflammation), As
shown in Figure 1, TSD in the MC group was signifi-
cantly greater than that in the NC group (P < 0.01).
After 30 day of drug administration, TSD values in all
groups were significantly lower than in the MC group
(P < 0.01 or P < 0.05). TSD in the XFC group was
94
JTCM |www. journaltcm. com February 15, 2016 |Volume 36 | Issue 1 |
Huang CB et al. / Experimental Study
substantially lower than in the MTX group (P < 0.05).
Compared with the NC group, measured on 12, 15,
and 19 day after induction of inflammation, the AI in
the MC group was substantially greater (P < 0.01).
The other groups showed no obvious differences in AI,
as compared with the MC group (P > 0.05). After 30
day of drug administration (on the 48th day of
FCA-induced inflammation), AI in the MC group re-
mained significantly greater than in the NC group
(P < 0.01). Compared with the MC group, AI values
in all the other groups were significantly lower (P <
0.01) and there were no significant differences in AI
among these groups (P > 0.05) (Figure 2).
Effects of XFC on parameters of cardiac function in
AA rats
Compared with in the NC group, HR, LVSP and
LVEDP in the MC group were substantially elevated
(P < 0.05) while ± dp /dtmax was substantially de-
creased (P < 0.05). Compared with in the MC group,
LVEDP was significantly lower (P < 0.05), but -dp/dt-
max was markedly increased in the MTX group (P <
0.05). LVSP and LVEDP were both significantly lower
in the XFC group (P < 0.05 or P < 0.01) while ±dp/dt-
max was clearly higher, as compared with these parame-
ters in the MC group (P < 0.05 or P < 0.01). Com-
pared with in the MTX group, LVSP and LVEDP were
both lower in the XFC group (P < 0.05) and +dp/dt-
max was higher (P < 0.05). These results are shown in
Table 1.
Effects of XFC on cardiac pathomorphology in AA
rats
HE staining (Figure 3) indicated that, compared with
the NC group (A), in hearts from the MC group (B)
interstitial edema of partial muscle fibers was apparent
and thickened portions of the cardiac muscle fibers
were partially fractured. Compared with the MC
group, interstitial edema of muscle fibers was substan-
tially lower in the MTX (C) and XFC (D) groups and
the cardiac muscle fibers were only partially disordered.
In the MTX group, cardiac muscle fibers appeared
slightly thickened. Compared with hearts from the
XFC group, edema and thickening of the cardiac mus-
cle fibers were more apparent in hearts from the MTX
group.
Figure 1 Effects of drug administration on TSD in AA rats
NC: normal control; MC: model control; MTX: methotrexate; XFC: Xinfeng capsule. The NC and MC groups were treated with 0.9%
normal saline (1 mL/100 g per day). The MTX group was treated with tripterygium glycosides tablet (1 mg/kg) once per week and
normal saline on other days. The XFC group was treated with Xinfeng capsule (1.2 g/kg) daily for 30 days. TSD: toe swelling de-
gree ; AA: adjuvant arthritis. Compared with the NC group, aP < 0.01; compared with the MC group, bP < 0.05 and cP < 0.01; com-
pared with the MTX group, dP < 0.05.
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Figure 2 Effects of drug administration on AI in AA rats
NC: normal control; MC: model control; MTX: Methotrexate; XFC: Xinfeng capsule. The NC and MC groups were treated with 0.9%
normal saline (1 mL/100 g per day). The MTX group was treated with tripterygium glycosides tablet (1 mg/kg) once per week and
normal saline on other days. The XFC group was treated with Xinfeng capsule (1.2 g/kg) daily for 30 days. AI: arthritis index; AA:
adjuvant arthritis. Compared with the NC group, aP < 0.01; compared with the MC group, bP < 0.05.
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Effects of XFC on myocardial cell ultrastructure in
AA rats
TEM showed, in the NC group (Figure 4A), a longitu-
dinal parallel-arrangement of myofibrils, clear Z lines
and homogeneous distribution of the myofilaments in
tight, well ordered arrangements. The location and
length of sarcomeres were normal as were the abundant
mitochondria, with extensive cristae, in orderly arrange-
ments. A small number of collagenous fibers were visi-
ble between cells. In the MC group (Figure 4B), TEM
showed a disordered arrangement of myofibrils, indis-
tinct Z lines, shortened sarcomeres and myofilaments
that were fractured, necrotic or dissolved. Mitochon-
dria were swelled, degenerated and necrotic and their
arrangements were disordered or they were translocat-
ed. Cristae spacing was expanded and the cristae were
less dense or in disordered arrangements. Hyperplasia
of the intercellular collagenous fibers was also evident.
In the MTX group (Figure 4C), the myocardial cell
morphology was essentially intact but sarcomere con-
nections were indistinct. Myofilament arrangements
were essentially in order, with mitochondria exhibiting
round or oval shapes between the myofilaments. Some
mitochondria were swollen with vacuolization. Cell nu-
clei were clear and and excess collagenous fibers be-
tween cells were evident. In the XFC group (Figure
4D), there was more normal myocardial cell morpholo-
gy with clear Z lines and connections between sarco-
meres, as well as orderly myofilament arrangement.
The mitochondria were partial or slightly swelled and
were arranged in round or oval shapes between myofila-
ments. The cristae of mitochondria were extensive, cell
nuclei were clear and a small amount of collagenous fi-
bers were observed between cells.
Effects of XFC on expression of NF-κB/TNF-α and
Smad pathway proteins in the heart
Compared with the NC group, cardiac tissue expres-
Group
NC
MC
MTX
XFC
n
12
12
12
12
HR (bpm)
356±18
394±7a
385±37
376±23b
LVSP (mm Hg)
119±21
150±4a
142±31
117±9bc
LVEDP (mm Hg)
1±7
6±3d
3±4b
2±5ce
+dp /dtmax (mm Hg/s)
12567±1076
7664±1655d
8438±1407
11079±894ce
-dp /dtmax (mm Hg/s)
8904±914
6398±1109a
7806±1265b
8073±1059b
Notes: NC: normal control; MC: model control; MTX: Methotrexate; XFC: Xinfeng capsule. The NC and MC groups were treated with
0.9% normal saline (1 mL/100 g per day). The MTX group was treated with tripterygium glycosides tablet (1 mg/kg) once per week and
normal saline on other days. The XFC group was treated with Xinfeng capsule (1.2 g/kg) daily for 30 days. HR: heart rate; LVSP: left ven-
tricular systolic pressure; LVEDP: left ventricular end-diastolic pressure; +dp/dtmax: maximum rate of left ventricular pressure rising/de-
scending. Compared with the NC group, aP < 0.05, dP < 0.01; Compared with the MC group, bP < 0.05, eP < 0.01; Compared with the
MTX group, cP < 0.05.
Table 1 Effects of XFC on indexes of cardiac function in AA rats ( xˉ ± s)
Figure 3 Comparative HE staining of heart tissue from treatment groups (×200)
A: NC group; B: MC group; C: MTX group; D: XFC group. The NC and MC groups were treated with 0.9% normal saline (1 mL/100 g
per day). The MTX group was treated with tripterygium glycosides tablet (1 mg/kg) once per week and normal saline on other
days. The XFC group was treated with Xinfeng capsule (1.2 g/kg) daily for 30 days. NC: normal control; MC: model control; MTX:
Methotrexate; XFC: Xinfeng capsule; HE: hematoxylin eosin.
A B C D
Figure 4 Comparative myocardial cell ultrastructure in tissue from treatment groups (TEM, × 15 000)
A: NC group; B: MC group; C: MTX group; D: XFC group. The NC and MC groups were treated with 0.9% normal saline (1 mL/100 g
per day). The MTX group was treated with tripterygium glycosides tablet (1 mg/kg) once per week and normal saline on other
days. The XFC group was treated with Xinfeng capsule (1.2 g/kg) daily for 30 days. NC: normal control; MC: model control; MTX:
Methotrexate; XFC: Xinfeng capsule; TEM: transmission electron microscope .
A B C D
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sion of TNF-α, NF-κB, Smad2, Smad4 and TGF-β1
proteins was elevated, while Smad7 expression was de-
creased. After both drug treatments, in comparison
with the MC group, protein expressions of NF-κB,
Smad2, and Smad4 were lower while Smad7 expres-
sion was elevated. In the XFC group, as compared with
the MTX group, NF-κB and TGF-β1 was lower while
Smad7 expression was higher (Figure 5).
Clustering analysis
Hierarchical clustering analysis was used and the re-
sults indicated these indexes could be classified into
three groups when the number was set as 6. In groupⅠ, AI, TSD, and parameters of cardiac function like
HR, LVSP, and LVEDP could be clustered. In groupⅡ, parameters of cardiac function were clustered with
the proteins TGF-β1, NF-κB, TNF-α, Smad2 and
Smad4. In group Ⅲ, TGF-β1 could be clustered with
NF-κB, Smad2 and Smad4 (Figure 6).
DISCUSSION
Overall performance in AA rats models the clinical
manifestations in RA patients. Injection of FCA into
the toe joints led to an early stage inflammatory re-
sponse and aggravated TSD. Toe swelling and inflam-
mation continued until they peaked and then gradual-
ly alleviated. The AI was increased by 12-14 day after
FCA-induced inflammation similar to the whole joint
lesions, characterized by swelling, remission, and
re-swelling, that are seen in the clinic. Therefore, the
AA model used in our study was useful to explore the
pathogenesis of RA. Pathologic changes of RA synovi-
tis and vasculitis may lead to injuries such as arrhyth-
mia, myocarditis, pericarditis and valvular disease.8 Le-
sions of cardiac tissue in RA might be regulated by
both the NF-κB/TNF-α and TGF-β1/Smads path-
ways. NF-κB is an important physiological mediator of
TNF-α, inducing TNF-α production when activated.9
As the degree of local joint inflammation increased in
AA rats, TNF-α expression became gradually in-
creased, including in cardiac tissue. Gene and protein
expression of NF-κB in cardiac tissue were consistent
with TNF-α expression, suggesting that NF-κB and
TNF-α are both important in the occurrence and de-
velopment of RA cardiac lesions.10 An imbalance in the
Smads signaling pathway stimulates increased forma-
tion of extracellular matrix in cardiac tissue, leading to
fibroblast proliferation and differentiation and exces-
sive collagen deposition. This inhibits myocardial pro-
liferation resulting in decreased cardiac function.11 Acti-
vation of the Smads pathway is regulated by TGF-β1.12
TGF-β1, with its proinflammatory properties, is in-
volved in the inflammatory processes of RA and related
disorders. Smad2, when dissociated from Smad, can be
phosphorylated to form P-Smad2, a process stimulated
by TGF-β1. P-Smad2 interacts with Smad4 to become
a polymer that relocates into the cell nucleus. This
combines with a transcriptional factor such as GATA4,
MEF2c, leading to excessive extracellular matrix deposi-
tion in the cardiac tissue, resulting in cardiac damage.
Smad7 plays an inhibitory role in the Smads family,
blocking the association of P-Smad2 and Smad4, thus
preventing activation of Smads pathway and inhibiting
formation of the complex between Smad4- P-Smad2
and the transcription factor.13 Thus, Smad7 can delay
progression of cardiac injuries in RA.14 In our study,
Smad7 expression in cardiac tissue was substantially
lower in AA rats, as compared with controls, while ex-
pression of TGF-β1, Smad2, P-Smad2 and Smad4
were elevated. These effects indicated that Smad7,
TGF-β1, Smad2, P-Smad2 and Smad4 might jointly
participate in the cardio-pulmonary abnormalities that
occur in AA rats. Excessive activation of the NF-κB/
TNF-α and TGF-β1/Smads pathways could directly
lead to aggravation of the inflammatory response and
to cardiac injuries.15 By hierarchical clustering analysis,
we found correlations between AI, TSD and parame-
ters of cardiac function in AA rats. Parameters of cardi-
ac function were also correlated with TGF-β1, NF-κB,
TNF-α, Smad2 and Smad4 expression. In addition,
Figure 5 Expression of NF-κB/TNF-α and Smad pathway pro-
teins from cardiac tissue in treatment groups
1: NC group; 2: MC group; 3: MTX group; 4: XFC group. The NC
and MC groups were treated with 0.9% normal saline (1 mL/
100 g per day). The MTX group was treated with tripterygi-
um glycosides tablet (1 mg/kg) once per week and normal
saline on other days. The XFC group was treated with Xin-
feng capsule (1.2 g/kg) daily for 30 days. TNF: tumor necrosis
factor; NF-κB: nuclear factor kappa-light-chain-enhancer of
activated B cell; TGF-β1: transforming growth factor-beta1;
NC: normal control; MC: model control; MTX: Methotrexate;
XFC: Xinfeng capsule.
TNF-α
NF-κB
TNF-β1
Smad2
P-Smad2
Smad4
Smad7
β-actin
kDa
55
60
40
56
58
61
46
43
1 2 3 4
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TGF-β1 was correlated with expression of NF-κB,
Smad2 and Smad4. Our experimental findings gave us
some hints that, after NF-κB/TNF-α signaling path-
way was activated, the inflammatory factors NF-κB
and TNF-α might be generated. At the same time, via
TGF-β1 induction, activation of the Smads pathway
occurred, stimulating increased formation of extracellu-
lar matrix in cardiac tissue, proliferation and differenti-
ation of fibroblasts, further effects on myocardial and
endo-/epicardial functions and, finally, impaired cardi-
ac function.
XFC has reported actions including boosting Qi, forti-
fying the spleen, and unblocking the collaterals. XFC
is composed of Yiyiren (Semen Coicis), Huangqi (Radix
Astragali Mongolici), Wugong (Scolopendra) and
Leigongteng (Radix et Rhizoma Tripterygii). Effective
components of Huangqi (Radix Astragali Mongolici) in-
clude total flavonoids of astragalus, astragalus polysac-
charide, astragaloside and total saponins. Total flavo-
noids of astragalus and astragalus polysaccharide can re-
duce secretion of serum inflammatory factors, greatly
improve synovitis changes in AA rats and alleviate in-
flammatory damages on the synovia of joints.16
Huangqi injections have shown a remarkable therapeu-
tic effect in the treatment of myocardial ischemia.17
Huangqi (Radix Astragali Mongolici) has effects that in-
clude dilating capillaries, boosting blood flow velocity,
improving microcirculation and myocardial nutrition,
strengthening contraction of cardiac muscle, reducing
myocardial oxygen consumption and alleviating myo-
cardial damage. Astragaloside has shown numerous ef-
fects on cardiac function, including slowing HR, hav-
ing a positive inotropic action on the heart and improv-
ing diastolic function, indicating that astragaloside
could strengthen myocardial contractility. Huangqi
(Radix Astragali Mongolici) decreased expression of
TGF-β1, TNF-α and NF-κB in myocardial tissue.18
This report suggested that astragaloside might alleviate
myocardial injuries by inhibiting expression of these
proteins in the heart. Total saponins from Huangqi
(Radix Astragali Mongolici) markedly improved myocar-
dial contractility in severe myocardial infarction and in-
creased coronary flow, protecting cardiac function.
Other reports showed that Huangqi (Radix Astragali
Mongolici) strongly inhibited gene- and protein-level
expression of TGF-β1 and Smad2/3 in cardiac mus-
cle.19 This suggested that Huangqi (Radix Astragali
Mongolici) prevented myocardial injuries by regulating
the TGF-β1/Smads signaling pathway. Extract of Yiy-
iren (Semen Coicis) increased the weight of immune or-
gans in mice with impaired immunity and improved
white blood cell count.20 Yiyiren (Semen Coicis) has an-
algesic effects and its extract inhibited reactive oxygen
species generation by neutrophils and phospholipase
A2 and prostaglandin E2 secretion by neutrophils and
lymphocytes and also affected pain-related cytokines.
Based on such effects, Yiyiren (Semen Coicis) has been
used as an anti-inflammatory agent, including to stabi-
lize inflammatory cells. In addition, its extract was re-
ported to notably alleviate myocardial injuries.21
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Figure 6 Clustering analysis of the parameters
1: AI; 2: TSD; 3: HR; 4: LVSP; 5: LVEDP; 6: dp/dtmax; 7: TNF-α; 8: NF-κB; 9: TGF-β1; 10: Smad2; 11: P-Smad2; 12: Smad4; 13: Smad7. AI:
arthritis index; HR: heart rate; LVSP: left ventricular systolic pressure; LVEDP: left ventricular end-diastolic pressure; + dp/dtmax:
maximum rate of left ventricular pressure rising/descending; TNF: tumor necrosis factor; NF-κB: nuclear factor kap-
pa-light-chain-enhancer of activated B cell; TGF-β1: transforming growth factor-beta1.Ⅰ,Ⅱ andⅢ refer to the results of cluster-
ing classification.
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Triptolide, as an effective component of Leigongteng
(Radix et Rhizoma Tripterygii), inhibited TNF-α-in-
duced responses and joint inflammation and swelling
in AA rats22 and decreased NF-κB activation. For exam-
ple, triptolide strongly suppressed NF-κB activation
stimulated by TNF-α,23 indicating a clear ability to im-
pact activation of the NF-κB pathway and expression
of inflammatory factors stimulated by TNF-α. Trip-
tolide decreased NF-κB activity in the synovium and
in myocardial cells and also decreased expression of
Smad2 and P-Smad2, while simultaneously upregulat-
ing Smad7 mRNA levels. Thus, triptolide upregulated
transcription of Smad7 and inhibited stimulation of in-
tracellular NF-κB activity and the Smads pathway.24
Triptolide reduced deposition of extracellular matrix
and improved synovial and myocardial injuries by inter-
fering with signal transduction by the TGF-β1/Smads
signaling pathway.25 Wugong (Scolopendra) not only im-
proved joint pain, but also enhanced myocardial func-
tion. Reported effects of Wugong (Scolopendra) include
dilating coronary arteries, improving myocardial isch-
emia and preventing myocardial injuries. Extract of
Wugong (Scolopendra) significantly improved cardiac
hemodynamics in rats and protected left cardiac func-
tion caused by an acute myocardial ischemia reperfu-
sion injury. In rats with impaired cardiac function, cen-
tipede acidic protein strengthened cardiac systolic func-
tion, improved myocardial cell lesions, decreased
TNF-α induced expression of inflammatory cytokines,
and exerted a protective role in cardiac muscle.26
Thus, the beneficial effects of its many components
might explain our findings that XFC improved arthrit-
ic symptoms as well as cardiac dysfunction in AA rats.
Our data further support the therapeutic value of XFC
in RA, not only for reducing the effects of joint inflam-
mation, but also as a cardioprotective agent.
REFERENCES
1 Gilek-Seibert K, Prescott K, Kazi S. Outcome assess-
ments in rheumatoid arthritis. Curr Rheumatol Rep 2013;
15(11): 370.
2 Crowson CS, Liao KP, Davis JM, et al. Rheumatoid ar-
thritis and cardiovascular disease. Am Heart J 2013; 166
(4): 622-628.
3 Chen XY, Wang ZC, Li J, Liu XL, Sun YH. Regulation of
synoviocyte activity by resveratrol in rats with adjuvant ar-
thritis. Exp Ther Med 2013; 6(1): 172-176.
4 Wan L, Liu J, Huang C, et al. Effects of Xinfeng capsule
on pulmonary function based on treg-mediated notch
pathway in a rat model of adjuvant arthritis. J Tradit Chin
Med 2012; 32(3): 430-436.
5 Umar S, Hedaya O, Singh AK, et al. Thymoquinone in-
hibits TNF-α-induced inflammation and cell adhesion in
rheumatoid arthritis synovial fibroblasts by ASK1 regula-
tion. Toxicol Appl Pharmacol 2015; 287(3): 299-305.
6 Cao YX, Liu J, Zhu Y. Effect of Xinfeng capsule on the
cardiac function in patients with rheumatoid arthritis.
Chin J Integr Med 2011; 17(10): 738-743.
7 Orhan CE, Önal A, Uyanıkgil Y, et al. Antihyperalgesic
and antiallodynic effect of sirolimus in rat model of adju-
vant arthritis. Eur J Pharmacol 2013; 705(1-3): 35-41.
8 Wojciechowska M, Wątroba M, Ciużyńska G, Bral M,
Szukiewicz D. Ischaemic heart preconditioning in rats
with adjuvant-induced arthritis. Kardiol Pol 2013; 71(8):
839-844.
9 Chu K, Zheng H, Li H, et al. Shuangtengbitong tincture
treatment of collagen-induced arthritis via downregulation
of the expression of IL-6, IL-8, TNF-α and NF-κB. Exp
Ther Med 2013; 5(2): 423-428.
10 Spurlock CF, Tossberg JT, Olsen NJ, et al. Cutting edge:
chronic NF-κB activation in CD4+ T cells in rheumatoid
arthritis is genetically determined by HLA risk alleles. J
Immunol 2015; 195(3): 791-795.
11 Zhan CY, Tang JH, Zhou DX, et al. Effects of tanshinone
IIA on the transforming growth factor β1/Smad signaling
pathway in rat cardiac fibroblasts. Indian J Pharmacol
2014; 46(6): 633-638.
12 Majesky MW. Choosing smads: smooth muscle ori-
gin-specific transforming growth factor-β signaling. Circ
Res 2013; 113(8): 946-948.
13 Wang T, Zhou XT, Yu Y, et al. Inhibition of corneal fibro-
sis by Smad7 in rats after photorefractive keratectomy.
Chin Med J (Engl) 2013; 126(8): 1445-1450.
14 Zhou H, Yang HX, Yuan Y, et al. Paeoniflorin attenuates
pressure overload-induced cardiac remodeling via inhibi-
tion of TGFβ/Smads and NF-κB pathways. J Mol Histol
2013; 44(3): 357-367.
15 Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY.
Loss of angiotensin-converting enzyme 2 enhances TGF-β/
Smad-mediated renal fibrosis and NF-κB-driven renal in-
flammation in a mouse model of obstructive nephropathy.
Lab Invest 2012; 92(5): 650-661.
16 Jiang JB, Qiu JD, Yang LH, He JP, Smith GW, Li HQ.
peutic effects of astragalus polysaccharides on inflamma-
tion and synovial apoptosis in rats with adjuvant-induced
arthritis. Int J Rheum Dis 2010; 13(4): 396-405.
17 Ma X, Zhang K, Li H, Han S, Ma Z, Tu P. Extracts from
Astragalus membranaceus limit myocardial cell death and
improve cardiac function in a rat model of myocardial isch-
emia. J Ethnopharmacol 2013; 149(3): 720-728.
18 He CL, Yi PF, Fan QJ, et al. Xiang-Qi-Tang and its active
components exhibit anti-inflammatory and anticoagulant
properties by inhibiting MAPK and NF-κB signaling path-
ways in LPS-treated rat cardiac microvascular endothelial
cells. Immunopharmacol Immunotoxico 2013; 35(2):
215-224.
19 He S, Yang Y, Liu X, et al. Compound Astragalus and Sal-
via miltiorrhiza extract inhibits cell proliferation, invasion
and collagen synthesis in keloid fibroblasts by mediating
transforming growth factor-β / Smad pathway. Br J Derma-
tol 2012; 166(3): 564-574.
20 Hu AJ, Zhao S, Liang H, Qiu TQ, Chen G. Ultrasound
assisted supercritical fluid extraction of oil and coixenolide
fromadlay seed.Ultrason Sonochem2007; 14(2): 219-224.
21 Wu Y, Li Y, Tong X, et al. The effect of coix seed on the
nutritional status of peritoneal dialysis patients: a pilot
study. Complement Ther Med 2014; 22(1): 40-48.
99
JTCM |www. journaltcm. com February 15, 2016 |Volume 36 | Issue 1 |
Huang CB et al. / Experimental Study
22 Liu C, Zhang Y, Kong X, et al. Triptolide Prevents Bone
Destruction in the Collagen-Induced Arthritis Model of
Rheumatoid Arthritis by Targeting RANKL/RANK/OPG
Signal Pathway. Evid Based Complement Alternat Med
2013; 2013: 626038.
23 Park SW, Kim YI. Triptolide induces apoptosis of
PMA-treated THP-1 cells through activation of caspases,
inhibition of NF-κB and activation of MAPKs. Int J On-
col 2013; 43(4): 1169-1175.
24 Chen M, Lv Z, Jiang S. The effects of triptolide on airway
remodelling and transforming growth factor-β / Smad sig-
nalling pathway in ovalbumin-sensitized mice. Immunolo-
gy 2011; 132(3): 376-384.
25 Zhang Z, Qu X, Ni Y, et al. Triptolide protects rat heart
against pressure overload-induced cardiac fibrosis. Int J
Cardiol 2013; 5273(13): 419-425.
26 Lin CC, Pan CS, Wang CY, et al. Tumor necrosis factor-al-
pha induces CAM-1-mediated inflammation via c-Src-de-
pendent transactivation of EGF receptors in human cardi-
ac fibroblasts. J Biomed Sci 2015; 22: 53.
100
